More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...
A long-acting injection designed to prevent HIV is set for approval in England and Wales. The cabotegravir (CAB-LA) treatment ...
South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...
Pre-exposure prophylaxis (PrEP) is a daily pill taken by HIV-negative people to prevent HIV infection. It can also be taken on demand before and after sex. The medicine stops the virus from getting ...
A “game-changing” injection to prevent HIV is set to be approved for use in England and Wales. The long-acting cabotegravir ...
17hon MSNOpinion
HIV rates highest in the American South, despite effective treatments: A clash between culture and public health
The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in ...
South Africa on Thursday welcomed a U.S. bridging plan worth $115 million that would continue funding HIV treatment and ...
Community advocates, health providers and local leaders in Charleston are all joining forces Wednesday in observance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback